This diagnostic approach is consistent with existing literature, which emphasizes that while CD99 is highly sensitive for Ewing sarcoma family tumors, it lacks specificity [15], making molecular confirmation-such as identification of the EWSR1-FLI1 translocation-critical. The gene discussed is CD99; the disease is Ewing sarcoma.